Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf Switching with Corticosteroid Reduction in Kidney Transplant
NCT02034747Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2013
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Envarsus XR in kidney transplant rejection, sponsored by Astellas Pharma. Started Nov 2013; status: completed.
02
Drugs
Envarsus XR
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02034747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034747.